FTC News

Opioid cessation products under attack by FTC & FDA

Together with the FDA, the FTC issued joint warning letters to 11 marketers and producers of allegedly unapproved opioid cessation products.  The letters allege that the companies used online platforms to make unsubstantiated claims about their products’ ability to treat opioid addiction and withdrawal.  Letters were sent to: Opiate Freedom Center (Opiate Freedom 5-Pack) U4Life, […]